Essential Role for Membrane Lipid Rafts in Interleukin-1β−Induced Nitric Oxide Release From Insulin-Secreting Cells
Potential Regulation by Caveolin-1+
- Rajakrishnan Veluthakal1,
- Irina Chvyrkova1,
- Marie Tannous2,
- Phillip McDonald3,
- Rajesh Amin3,
- Timothy Hadden23,
- Debbie C. Thurmond4,
- Michael J. Quon5 and
- Anjaneyulu Kowluru13
- 1Department of Pharmaceutical Sciences, Wayne State University, Detroit, Michigan
- 2Department of Internal Medicine, Wayne State University, Detroit, Michigan
- 3β Cell Biochemistry Research Laboratory, John D. Dingell VA Medical Center, Detroit, Michigan
- 4Department of Biochemistry and Molecular Biology, Center for Diabetes Research, Indiana University School of Medicine, Indianapolis, Indiana
- 5National Center for Complementary and Alternative Medicine, National Institutes of Health, Bethesda, Maryland
- Address correspondencereprint requests to Anjaneyulu Kowluru, PhD, Department of Pharmaceutical Sciences, Wayne State University, 259 Mack Ave., Detroit, MI 48201. E-mail: akowluru{at}med.wayne.edu
Abstract
We recently reported that the activation of H-Ras represents one of the signaling steps underlying the interleukin-1β (IL-1β)−mediated metabolic dysfunction of the islet β-cell. In the present study, we examined potential contributory roles of membrane-associated, cholesterol-enriched lipid rafts/caveolae and their constituent proteins (e.g., caveolin-1 [Cav-1]) as potential sites for IL-1β−induced nitric oxide (NO) release in the isolated β-cell. Disruption of lipid rafts (e.g., with cyclodextrin) markedly reduced IL-1β−induced gene expression of inducible NO synthase (iNOS) and NO release from β-cells. Immunologic and confocal microscopic evidence also suggested a transient but significant stimulation of tyrosine phosphorylation of Cav-1 in β-cells briefly (for 15 min) exposed to IL-1β that was markedly attenuated by three structurally distinct inhibitors of protein tyrosine phosphorylation. Overexpression of an inactive mutant of Cav-1 lacking the tyrosine phosphorylation site (Y14F) or an siRNA-mediated Cav-1 knock down also resulted in marked attenuation of IL-1β–induced iNOS gene expression and NO release from these cells, thus further implicating Cav-1 in this signaling cascade. IL-1β treatment also increased (within 20 min) the translocation of H-Ras into lipid rafts. Here we provide the first evidence to suggest that tyrosine phosphorylation of Cav-1 and subsequent interaction among members of the Ras signaling pathway within the membrane lipid microdomains represent early signaling mechanisms of IL-1β in β-cells.
- Cav-1, caveolin-1
- FITC, fluorescein isothiocyanate
- β-Gal, β-galactosidase
- IL-1β, interleukin-1β
- iNOS, inducible nitric oxide synthase
- MCD, methyl-β-cyclodextrin
- Mes, morpholine-ethanesulfonic acid
Footnotes
-
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
- Accepted May 31, 2005.
- Received March 2, 2005.
- DIABETES














